NICE recommends Kymriah® for routine NHS use, offering immense benefits for those with resistant B-...
Read moreConsultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp...
Read moreANSM establishes a Temporary Scientific Committee to promote biosimilar substitution, enhancing pati...
Read moreNew website provides regular updates on NLF's work, addresses challenges, and showcases collaboratio...
Read moreNew biosimilar switching regulations prioritise cost-effective options and discount agreements, imp...
Read moreOur analysts explore NICE's integration of tech appraisals into treatment guidelines for to enable o...
Read moreProposed changes in Germany's pharma strategy suggest replacing publicly listed AMNOG rebates with c...
Read moreAIFA's restructuring in Italy aims to streamline drug approval, replacing committees and introducing...
Read moreSpain seeks to enhance financing for orphan drug access, signalling a push for better timelines and ...
Read moreNICE set to endorse talazoparib for adults with BRCA 1 or 2 mutated HER2-negative locally advanced o...
Read more